{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:14Z","timestamp":1786979894552,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Clinical Study of Shanghai Municipal Health Commission","award":["No.20194Y0473"],"award-info":[{"award-number":["No.20194Y0473"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-023-04089-4","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T04:02:21Z","timestamp":1700798541000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma"],"prefix":"10.1007","volume":"49","author":[{"given":"Jianan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiannan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4511-0188","authenticated-orcid":false,"given":"Yanling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"issue":"5","key":"4089_CR1","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2021.01.035","volume":"74","author":"A Beaufr\u00e8re","year":"2021","unstructured":"Beaufr\u00e8re A, Calderaro J, Paradis V. Combined hepatocellular-cholangiocarcinoma: An update. Journal of hepatology. 2021;74(5):1212-1224.","journal-title":"Journal of hepatology."},{"issue":"4","key":"4089_CR2","first-page":"647","volume":"25","author":"RA Allen","year":"1949","unstructured":"Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol. 1949;25(4):647-655.","journal-title":"Am J Pathol."},{"issue":"2","key":"4089_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182-188.","journal-title":"Histopathology."},{"issue":"6","key":"4089_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.hbpd.2020.07.004","volume":"19","author":"D Schizas","year":"2020","unstructured":"Schizas D, Mastoraki A, Routsi E, et al. Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management. Hepatobiliary Pancreat Dis Int. 2020;19(6):515-523.","journal-title":"Hepatobiliary Pancreat Dis Int."},{"issue":"6","key":"4089_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198138","volume":"13","author":"SK Na","year":"2018","unstructured":"Na SK, Choi GH, Lee HC, et al. The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection. PloS one. 2018;13(6):e0198138.","journal-title":"PloS one."},{"key":"4089_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.crad.2021.10.013","volume":"77","author":"A Mukund","year":"2022","unstructured":"Mukund A, Srinivasan S, Rana S, et al. Response evaluation of locoregional therapies in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study. Clinical radiology. 2022;77:121\u2013129.","journal-title":"Clinical radiology."},{"issue":"1","key":"4089_CR7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1186\/s12885-020-07138-z","volume":"20","author":"WR Liu","year":"2020","unstructured":"Liu WR, Tian MX, Tao CY, et al. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis. BMC cancer. 2020;20(1):642.","journal-title":"BMC cancer."},{"issue":"9","key":"4089_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jvir.2019.03.024","volume":"30","author":"YH Huang","year":"2019","unstructured":"Huang YH, Park BV, Chen YF, Gaba RC, Guzman G, Lokken RP. Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study. Journal of vascular and interventional radiology : JVIR. 2019;30(9):1317-1324.","journal-title":"Journal of vascular and interventional radiology : JVIR."},{"key":"4089_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","volume":"23","author":"t Yau","year":"2022","unstructured":"Yau T, Park JW, Finn RS, et al. Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial. The Lancet Oncology. 2022;23:77\u201390.","journal-title":"The Lancet Oncology."},{"issue":"23","key":"4089_CR10","doi-asserted-by":"publisher","first-page":"13071","DOI":"10.3390\/ijms222313071","volume":"22","author":"T Shi","year":"2022","unstructured":"Shi T, Iwama H, Fujita K, et al. Evaluating the effect of lenvatinib on sorafenib-resistant hepatocellular carcinoma cells. International journal of molecular sciences. 2021;22(23):13071.","journal-title":"International journal of molecular sciences."},{"issue":"1","key":"4089_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","volume":"73","author":"A Lamarca","year":"2020","unstructured":"Lamarca A, Barriuso J, McNamara MG, Valle JW. Molecular targeted therapies: Ready for \u201cprime time\u201d in biliary tract cancer. Journal of hepatology. 2020;73(1):170-185.","journal-title":"Journal of hepatology."},{"issue":"6","key":"4089_CR12","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/liv.14813","volume":"41","author":"EJ Kim","year":"2021","unstructured":"Kim EJ, Yoo C, Kang HJ, et al. Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinoma. Liver international : official journal of the International Association for the Study of the Liver. 2021;41(6):1398-1408.","journal-title":"Liver international : official journal of the International Association for the Study of the Liver."},{"issue":"10","key":"4089_CR13","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.6004\/jnccn.2018.7053","volume":"16","author":"NA Trikalinos","year":"2018","unstructured":"Trikalinos NA, Zhou A, Doyle MBM, et al. Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience. Journal of the National Comprehensive Cancer Network : JNCCN. 2018;16(10):1193-1199.","journal-title":"Journal of the National Comprehensive Cancer Network : JNCCN."},{"key":"4089_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.12659\/AOT.900779","volume":"22","author":"CC Chang","year":"2017","unstructured":"Chang CC, Chen YJ, Huang TH, et al. Living Donor Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Experience of a Single Center. Ann Transplant. 2017;22:115-120.","journal-title":"Ann Transplant."},{"issue":"6","key":"4089_CR15","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. Journal of hepatology. 2014;60(6):1268-1289.","journal-title":"Journal of hepatology."},{"issue":"7","key":"4089_CR16","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/lt.25786","volume":"26","author":"ML Holzner","year":"2020","unstructured":"Holzner ML, Tabrizian P, Parvin-Nejad FP, et al. Resection of Mixed Hepatocellular-Cholangiocarcinoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2020;26(7):888-898.","journal-title":"Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society."},{"issue":"4","key":"4089_CR17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/cancers12040794","volume":"12","author":"S Leoni","year":"2020","unstructured":"Leoni S, Sansone V, Lorenzo S, et al. Treatment of combined hepatocellular and cholangiocarcinoma. Cancers. 2020;12(4):794.","journal-title":"Cancers."},{"issue":"7","key":"4089_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/hepr.13507","volume":"50","author":"YI Yamashita","year":"2020","unstructured":"Yamashita YI, Aishima S, Nakao Y, et al. Clinicopathological characteristics of combined hepatocellular cholangiocarcinoma from the viewpoint of patient prognosis after hepatic resection: High rate of early recurrence and its predictors. Hepatology research : the official journal of the Japan Society of Hepatology. 2020;50(7):863-870.","journal-title":"Hepatology research : the official journal of the Japan Society of Hepatology."},{"issue":"1","key":"4089_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/MCG.0b013e3181ce5dfa","volume":"45","author":"JH Lee","year":"2011","unstructured":"Lee JH, Chung GE, Yu SJ, et al. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol. 2011;45(1):69-75.","journal-title":"J Clin Gastroenterol."},{"issue":"13","key":"4089_CR20","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1002\/cam4.2495","volume":"8","author":"P Song","year":"2019","unstructured":"Song P, Midorikawa Y, Nakayama H, et al. Patients\u2019 prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection. Cancer medicine. 2019;8(13):5862-5871.","journal-title":"Cancer medicine."},{"issue":"8","key":"4089_CR21","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1007\/s00261-021-03085-w","volume":"46","author":"AA Borhani","year":"2021","unstructured":"Borhani AA, Catania R, Velichko YS, Hectors S, Taouli B, Lewis S. Radiomics of hepatocellular carcinoma: promising roles in patient selection, prediction, and assessment of treatment response. Abdom Radiol (NY). 2021;46(8):3674-3685.","journal-title":"Abdom Radiol (NY)."},{"issue":"7","key":"4089_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11071194","volume":"11","author":"A Castaldo","year":"2021","unstructured":"Castaldo A, De Lucia DR, Pontillo G, et al. State of the art in artificial intelligence and radiomics in hepatocellular carcinoma. Diagnostics (Basel). 2021;11(7):1194.","journal-title":"Diagnostics (Basel)."},{"key":"4089_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3544","volume":"371","author":"JD Yang","year":"2020","unstructured":"Yang JD, Heimbach JK. New advances in the diagnosis and management of hepatocellular carcinoma. Bmj. 2020;371:m3544.","journal-title":"Bmj."},{"issue":"4","key":"4089_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.semradonc.2018.06.010","volume":"28","author":"EC Lo","year":"2018","unstructured":"Lo EC, A NR, Federle MP. Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Imaging for Diagnosis, Tumor Response to Treatment and Liver Response to Radiation. Seminars in radiation oncology. 2018;28(4):267-276.","journal-title":"Seminars in radiation oncology."},{"issue":"1","key":"4089_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40644-018-0142-z","volume":"18","author":"J Sammon","year":"2018","unstructured":"Sammon J, Fischer S, Menezes R, et al. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma. Cancer imaging : the official publication of the International Cancer Imaging Society. 2018;18(1):8.","journal-title":"Cancer imaging : the official publication of the International Cancer Imaging Society."},{"issue":"10","key":"4089_CR26","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3348\/kjr.2020.0091","volume":"21","author":"TH Kim","year":"2020","unstructured":"Kim TH, Kim H, Joo I, Lee JM. Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis. Korean J Radiol. 2020;21(10):1115-1125.","journal-title":"Korean J Radiol."},{"issue":"4","key":"4089_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.dld.2017.11.003","volume":"50","author":"Y Dong","year":"2018","unstructured":"Dong Y, Teufel A, Trojan J, Berzigotti A, Cui XW, Dietrich CF. Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature. Dig Liver Dis. 2018;50(4):401-407.","journal-title":"Dig Liver Dis."},{"issue":"8","key":"4089_CR28","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1007\/s00261-020-02545-z","volume":"45","author":"MY Kim","year":"2020","unstructured":"Kim MY, Joo I, Kang HJ, Bae JS, Jeon SK, Lee JM. LI-RADS M (LR-M) criteria and reporting algorithm of v2018: diagnostic values in the assessment of primary liver cancers on gadoxetic acid-enhanced MRI. Abdom Radiol (NY). 2020;45(8):2440-2448.","journal-title":"Abdom Radiol (NY)."},{"issue":"7","key":"4089_CR29","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1007\/s00261-021-02996-y","volume":"46","author":"X Zou","year":"2021","unstructured":"Zou X, Luo Y, Morelli JN, Hu X, Shen Y, Hu D. Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in high-risk patients matched to MR field strength: diagnostic performance of LI-RADS version 2018. Abdominal radiology (New York). 2021;46(7):3168-3178.","journal-title":"Abdominal radiology (New York)."},{"issue":"5","key":"4089_CR30","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1007\/s00330-018-5893-1","volume":"29","author":"HS Lee","year":"2019","unstructured":"Lee HS, Kim MJ, An C. How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI? European radiology. 2019;29(5):2408-2416.","journal-title":"European radiology."},{"key":"4089_CR31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12885-016-2156-x","volume":"16","author":"R Li","year":"2016","unstructured":"Li R, Yang D, Tang CL, et al. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography. BMC cancer. 2016;16:158.","journal-title":"BMC cancer."},{"issue":"7","key":"4089_CR32","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/apt.16563","volume":"54","author":"E Harding-Theobald","year":"2021","unstructured":"Harding-Theobald E, Louissaint J, Maraj B, et al. Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma. Aliment Pharmacol Ther. 2021;54(7):890-901.","journal-title":"Aliment Pharmacol Ther."},{"key":"4089_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.672055","volume":"11","author":"H Zhou","year":"2021","unstructured":"Zhou H, Jiang T, Li Q, et al. US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients. Frontiers in oncology. 2021;11:672055.","journal-title":"Frontiers in oncology."},{"issue":"9 Pt B","key":"4089_CR34","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacr.2019.06.004","volume":"16","author":"Z Akkus","year":"2019","unstructured":"Akkus Z, Cai J, Boonrod A, et al. A Survey of Deep-Learning Applications in Ultrasound: Artificial Intelligence-Powered Ultrasound for Improving Clinical Workflow. J Am Coll Radiol. 2019;16(9 Pt B):1318-1328.","journal-title":"J Am Coll Radiol."},{"issue":"32","key":"4089_CR35","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.3748\/wjg.v27.i32.5341","volume":"27","author":"B Feng","year":"2021","unstructured":"Feng B, Ma XH, Wang S, Cai W, Liu XB, Zhao XM. Application of artificial intelligence in preoperative imaging of hepatocellular carcinoma: Current status and future perspectives. World journal of gastroenterology. 2021;27(32):5341-5350.","journal-title":"World journal of gastroenterology."},{"issue":"1","key":"4089_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40644-021-00425-3","volume":"21","author":"SC Liu","year":"2021","unstructured":"Liu SC, Lai J, Huang JY, et al. Predicting microvascular invasion in hepatocellular carcinoma: a deep learning model validated across hospitals. Cancer imaging : the official publication of the International Cancer Imaging Society. 2021;21(1):56.","journal-title":"Cancer imaging : the official publication of the International Cancer Imaging Society."},{"issue":"4","key":"4089_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21037\/atm.2020.01.126","volume":"8","author":"J Zhang","year":"2020","unstructured":"Zhang J, Huang Z, Cao L, et al. Differentiation combined hepatocellular and cholangiocarcinoma from intrahepatic cholangiocarcinoma based on radiomics machine learning. Ann Transl Med. 2020;8(4):119.","journal-title":"Ann Transl Med."},{"issue":"1","key":"4089_CR38","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00330-020-07119-7","volume":"31","author":"X Liu","year":"2021","unstructured":"Liu X, Khalvati F, Namdar K, et al. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning? Eur Radiol. 2021;31(1):244-255.","journal-title":"Eur Radiol."},{"key":"4089_CR39","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3389\/fonc.2020.01646","volume":"10","author":"Y Peng","year":"2020","unstructured":"Peng Y, Lin P, Wu L, et al. Ultrasound-Based Radiomics Analysis for Preoperatively Predicting Different Histopathological Subtypes of Primary Liver Cancer. Front Oncol. 2020;10:1646.","journal-title":"Front Oncol."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-04089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-023-04089-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-04089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T21:06:18Z","timestamp":1705352778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-023-04089-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["4089"],"URL":"https:\/\/doi.org\/10.1007\/s00261-023-04089-4","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"22 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}